MAGA law group fights to expose how Biden's DEI agenda may have tainted life-saving organ transplants
MAGA law group America First Legal is suing a number of federal health agencies to obtain documents related to the nation's organ transplant system.
Specifically, they're targeting the Department of Health and Human Services, the Centers for Medicare and Medicaid Services and the Health Resources Services Administration, in an attempt to compel them to turn over documents related to the Organ Procurement and Transplantation Network (OPTN).
In April 2023, AFL filed a Freedom of Information Act (FOIA) request seeking documents relevant to the Biden administration's efforts to infuse DEI into the organ transplant system. However, to date, AFL says it has not received any of the requested information and, as a result, decided to sue in an effort to compel the release of it.
"The Biden Administration infected the federal government with 'equity,' replacing traditional principles of fairness and need with race-conscious criteria," said America First Legal Counsel Will Scolinos. "AFL is determined to uncover the complete scope of Biden-era DEI policies and will continue to take decisive action to restore colorblind healthcare."
Just days after taking office in 2021, former President Joe Biden signed Executive Order 13985, directing all federal agencies to conduct "Equity Assessments" to determine whether "underserved communities and their members" faced systemic barriers to accessing federal programs. The order also required each agency to develop an action plan to address those barriers.
As part of this effort, in December 2021, CMS issued a request to the public for comments on how the agency could "Advance Equity and Reduce Disparities in Organ Transplantation."
"CMS is focused on identifying potential system-wide improvements that would increase organ donations, improve transplants, enhance the quality of care in dialysis facilities, increase access to dialysis services, and advance equity in organ donation and transplantation," the agency said at the time.
"Communities of color have much higher rates of high blood pressure, diabetes, obesity, and heart disease, all of which increase the risk for kidney disease. Black Americans are almost four times more likely, and Latinos are 1.3 times more likely, to have kidney failure compared to White Americans. Despite the higher risk, data shows that Black and Latino patients on dialysis are less likely to be placed on the transplant waitlist and have a lower likelihood of transplantation. Because of these stark inequities, CMS' [Request For Information] asks the public for specific ideas on advancing equity within the organ transplantation system."
Meanwhile, several weeks later, the HRSA announced that the "labeling of race and ethnicity information for organ donors" would "change on a number of data reports available on the Organ Procurement and Transplantation Network (OPTN) website." According to the HRSA, the move made the data "clearer, more consistent and easier for users to interpret," and did not impact the manner in which data is collected. OPTN collects and manages data pertaining to the patient waiting list, organ donation, matching and transplantation in the U.S.
HRSA also announced a "modernization initiative" for OPTN around the same time, which included plans to strengthen "equity, and performance in the organ donation and transplantation system."
In its lawsuit, AFL chronicled a series of delays, non-responses and incomplete communications following its April 2023 FOIA request. AFL is hoping to obtain a judge's order requiring the release of the records it is seeking, as well as an index of any withheld material and explanations for why it could not be provided.
"The last administration's pervasive directives requiring consideration of immutable characteristics like race, color, and ethnicity — to make healthcare more 'equitable' — should concern all Americans," Scolinos said Tuesday. "AFL is determined to uncover the complete scope of Biden-era DEI policies and will continue to take decisive action to restore colorblind healthcare."
HHS declined to comment on AFL's lawsuit.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
41 minutes ago
- Yahoo
Trump Aims to Shut Trade Loopholes China Uses to Evade Tariffs
(Bloomberg) -- President Donald Trump's two-tiered trade deal with Vietnam aims squarely at practices China has long used to skirt US tariffs: The widespread legal shifting of production to Southeast Asian factories and the murkier and illegal 'origin washing' of exports through their ports. NYC Commutes Resume After Midtown Bus Terminal Crash Chaos Struggling Downtowns Are Looking to Lure New Crowds Massachusetts to Follow NYC in Making Landlords Pay Broker Fees What Gothenburg Got Out of Congestion Pricing California Exempts Building Projects From Environmental Law The agreement slaps a 20% tariff on Vietnamese exports to the US and a 40% levy on goods deemed to be transshipped through the country. With details still scarce, economists said much will hinge on the framework Washington establishes to determine what it sees as 'Made in Vietnam' and what it sees as transshipments. Complicating matters is the fact that Chinese businesses have rushed to set up shop across Southeast Asia since Trump launched his first trade war back in 2018. The lion's share of Vietnam's exports to the US are goods like Airpods, phones or other products assembled with Chinese components in a factory in Vietnam and then shipped to America. That's not illegal. 'A lot will depend on how the 40% tariffs are applied. If the Trump administration keeps it targeted, it should be manageable,' said Roland Rajah, lead economist at the Lowy Institute in Sydney. 'If the approach is too broad and blunt, then it could be quite damaging' for China, Vietnam and for the US, which will have to pay higher import prices, he said. The think tank estimates that 28% of Vietnamese exports to the US were made up of Chinese content in 2022, up from 9% in 2018. Pham Luu Hung, chief economist at SSI Securities Corp. in Hanoi, said a 40% levy on transshipped goods would have limited impact on Vietnam's economy because they aren't of Vietnamese origin in the first place. Re-routed exports accounted for just 16.5% of Vietnam's shipments to the US in 2021, a share that's likely declined over the past couple of years amid stronger enforcement actions by both governments, Hung said. 'An important caveat is that the rules of origin remain under negotiation,' Hung said. 'In practice, these rules may have a greater impact than the tariff rates themselves.' Devil in Details Duncan Wrigley, chief China economist at Pantheon Macroeconomics, said he's skeptical the latest deal will be effective in stamping out Chinese exports via Vietnam to the US. 'The devil is in the details, but I think China's exports will either go via other markets to the US, or some value-added will be done in Vietnam so the product counts as made in Vietnam, rather than a transshipment,' he said. As officials across Asia rushed to negotiate lower US tariff levels with their US counterparts this year, Chinese businesses have been just as quick to ramp up their exports through alternative channels in order to skirt punitive US levies. Shipments from China to Southeast Asia have reached record highs in Indonesia, Malaysia, Thailand and Vietnam this year. And there's been a 'significant increase in correlation' to the region's increase in exports to the US during the same period, Citigroup Inc. economists said in a recent report. Much of that is likely due to the shifting of legitimate production across the region. Goods destined for the US market may be sent from their factories in Southeast Asia, and what they make in their factories in China will be sent to the rest of the world, said Derrick Kam, Asia economist at Morgan Stanley. 'If you try to represent that in the trade data, it will look exactly like rerouting, but it's not,' Kam said. 'It's essentially the supply chain working itself out.' But it's transshipment that's been a major concern for Trump's top trade advisers including Peter Navarro, who described Vietnam as 'essentially a colony of communist China' during an April interview with Fox News. And it's not just been happening in Vietnam. Not long after Trump unveiled his 'Liberation Day' tariffs on April 2, garment makers in Indonesia started receiving offers from Chinese companies to be 'partners in transshipment,' said Redma Gita Wirawasta, chairman of the Indonesian Filament Yarn and Fiber Producers Association. Chinese products would be rerouted to Indonesia, undergo minimal processing like repacking or relabeling, then secure a certification that they were made in the Southeast Asian country, Wirawasta said. When the goods are then exported to the US, they'd be subject to the 10% universal levy that Trump has imposed on nearly all countries, instead of the tariff for China that still equates to an effective level of over 50%, even after a recent 'deal' that lowered levies from a peak of 145%. With the huge scope for arbitrage, coupled with little policing, that process will prove tough to stamp out. 'Chinese exporters and their affiliates and partners in Southeast Asia are highly skilled at adapting to changing rules, identifying loopholes, and sometimes overstating the extent of value-add by non-China countries,' said Gabriel Wildau, managing director at advisory firm Teneo Holdings LLC in New York. Some final assembly or transshipment may shift to rival Southeast Asian transshipment hubs like Cambodia, Thailand and Singapore, or farther afield to Turkey, Hungary or Poland, Wildau said. 'Another possibility is that the definitions and enforcement mechanisms are fuzzy, rendering the latest deal cosmetic and toothless,' he said. 'Rigorous enforcement would also require a significant boost of resources to enable US customs to verify compliance with the tougher rules of origin.' There have been efforts across the region to at least be seen to be making an effort to curb the practice. Indeed, Vietnam has made a big deal about cracking down on trade fraud and illegal activity in recent months. In April, South Korea said it seized more than $20 million worth of goods with falsified origin labels — the majority of which were destined for the US. The Airfreight Forwarders Association of Malaysia issued a warning in May as Chinese brokers promoted illegal rerouting services on social media. Malaysia has centralized the issuance of certificates of origin with its Ministry of Investment, Trade and Industry, while tapping its customs agency to help curb transshipment. Thailand has expanded its watch list for high-risk products, including solar panels, cars and parts, and is mulling stricter penalties for violators. Red Tape Casey Barnett, the president of the American Chamber of Commerce in Cambodia, is already seeing the changes in action. One factory that exports to major US retailers, including Walmart, Home Depot and Lowe's, said that customs officials were very carefully reviewing their products before being sent to the US, he said. 'It's creating some additional paperwork and a little bit of red tape here,' Barnett said. A senior manager at a logistics company in Cambodia, who asked not to be identified because the matter is sensitive, said export processing time has now stretched to as much as 14 working days — double what it was before. But in Indonesia, getting a certificate of origin is fairly quick and painless when goods are marked for export, often just requiring a product list and a letter to the provincial trade office, according to Wirawasta. Authorities prioritize checking products that enter the country to ensure they pay the right duties and comply with regulations, he explained. It's rare for them to inspect factories where an export good was supposedly made. So much so that sometimes, Chinese companies don't even need to muster up some local processing. 'The T-shirt could be finished in China, with a 'Made in Indonesia' label already sewn on,' Wirawasta said. 'Some traders won't even bother to unload the goods from the shipping container,' he added. 'Unloading costs money.' --With assistance from James Mayger, Spe Chen, Nguyen Kieu Giang and Jacob Gu. SNAP Cuts in Big Tax Bill Will Hit a Lot of Trump Voters Too America's Top Consumer-Sentiment Economist Is Worried How to Steal a House China's Homegrown Jewelry Superstar Pistachios Are Everywhere Right Now, Not Just in Dubai Chocolate ©2025 Bloomberg L.P. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
42 minutes ago
- Yahoo
Regular cannabis use can cause a serious vomiting syndrome. Should people be warned?
When Brittany Ramsey started experiencing "awful stomach episodes" she thought it must've been side effects of the medication she was taking to manage her diabetes. But after a particularly gruelling episode where she just could not stop vomiting — not being keep down even small sips of water — that landed her in hospital, Ramsey knew something felt different about what she was experiencing. "From then, the episodes got worse and worse, and closer together," said Ramsey, a 35-year-old operations trainer at a financial firm in Cincinnati, Ohio. "From 2021 to 2024 … three years, I was hospitalized 29 times. Five ambulance trips – one actually had to pick me up on the side of the road because I couldn't make it to the hospital." After years of undergoing, at times, invasive testing procedures to rule out Crohn's disease, gastroparesis and diverticulitis, a doctor told Ramsey about cannabis hyperemesis syndrome (CHS). In recent years some emergency rooms have been seeing an uptick in visits due to cyclic episodes of uncontrollable vomiting in cannabis users, often characterized by experiencing temporary relief with hot showers and baths. Since it was first identified in medical literature in 2004, CHS cases have increased, possibly because of greater cannabis access or higher THC potency of products. Public health researchers suggest more awareness of CHS within the health-care system is needed for cannabis users to get the information and support they need. More CHS cases in the ER CHS is characterized by "severe and persistent vomiting" and is usually seen in people who have been using cannabis several times a week for multiple years, said Jamie Seabrook, a professor at the Department of Epidemiology and Biostatistics at Western University in London, Ont. Ramsey said she'd been smoking at least once a day for over 10 years since she was 18 when she first started experiencing CHS symptoms in 2017. A 2022 study by researchers at the Ottawa Hospital Research Institute looked at the rate of emergency department visits for CHS after recreational cannabis was legalized and commercialized in Ontario, looking at nearly 13,000 CHS-related hospitalizations in Ontario from 8,140 individuals between 2014 and 2021. The study, published in the Journal of the American Medical association (JAMA), found that emergency department visits related to CHS had increased by 13-fold over a period of nearly eight years. The study doesn't show what caused the change, but the authors noted that the biggest increase in visits came not after legalization in 2018 but after Ontario allowed expansion of retail stores in 2020, which coincided with the COVID-19 pandemic. Though we don't have numbers how many people have been diagnosed or hospitalized with CHS, online communities are filled with people looking for support. Ramsey is part of one of them — a CHS Facebook group described as a "safe place to recover and learn" with 3,000 members. The largest CHS Facebook group has 31,000 members. On Reddit, the group r/CHSinfo has 20,000 members, with discussions ranging from tips on how to manage episodes and personal anecdotes about repeated hospitalizations. Seabrook, who co-authored a recent review of existing research on CHS in youth, said there's been an "explosion" of people showing up in some North American emergency rooms with CHS within the last seven to eight years. The Ottawa Hospital Research Institute study showed that other cannabis-related emergency room visits, including for intoxication and dependence, saw a substantial increase starting in early 2020 as well. Surge in THC potency since the 1980s Seabrook said a likely reason for increased rates of CHS is the high THC potency of cannabis products today. THC is the compound in cannabis that is responsible for the sensation of a high most people experience when consuming it. When its potency increases, so do its harmful effects. Different strains of the plant will have different concentrations of active compounds, measured by percentage of total weight or volume. On average, THC content is much higher today than it used to be. "The potency of THC was only about three per cent in the 1980s and today, according to Health Canada, the average is 15 per cent with some strains as high as 30 per cent," Seabrook said, citing Health Canada numbers for "fresh or dried herb material." "So we're talking a 400 per cent or higher increase in the potency." For "chemically concentrated extracts," such as hash oil, shatter, budder and wax, the typical potency can be up to 90 per cent, according to Health Canada data. "The potency, I think, is what's causing the illnesses to become more and more prevalent, because they're smoking a lot more potent stuff," Ramsey said. "And that's the same with me. When I first started smoking, it was my brother's homegrown stuff, versus getting it from friends and dispensaries out in California, where it does get stronger and stronger." "I feel like maybe before just making marijuana available to the masses, maybe some of these things should have been looked into. You know, too much of anything might be bad," said Ramsey. Lawsuit against Aurora Cannabis cites CHS A lawsuit was recently brought against Canadian cannabis production company Aurora Cannabis for alleged negligence of failing to warn consumers about the potential risk for developing CHS from the regular use of its products. The lawsuit was certified by the Ontario Superior Court of Justice last month, meaning it can proceed as a class action. Margaret Waddell, the lawyer prosecuting the case, said she hopes that if the lawsuit is successful, it could have an industry-wide effect on including CHS in their product labelling. "Ideally, Health Canada will require them at some point," Waddell said. Health Canada does require cannabis manufacturers to warn customers about specified risks — including psychotic symptoms, addiction and dependence — but Waddell said there aren't currently any requirements to specifically include CHS in those warnings. Aurora Cannabis declined to comment on the lawsuit, writing in an emailed statement: "It is the company's practice not to comment on legal matters beyond information that is made available to the public." "Information that [CHS] exists is very important," Seabrook said. "In schools, in health-care settings – whether that's neurologists, psychiatrists, [emergency room] doctors – and public health campaigns, so people can make a better informed decision about their cannabis use."
CNN
42 minutes ago
- CNN
Live updates: Trump's ‘big, beautiful bill' awaits House vote
Update: Date: 4 min ago Title: Speaker Johnson says he expects final passage of Trump agenda bill later this morning Content: Speaker Mike Johnson told reporters that he expects final passage of the president's sweeping domestic policy bill around 8 a.m. ET, noting that President Donald Trump has been speaking with members throughout the night. Timing for passage of the bill is fluid, however, and it's not yet clear exactly when a final vote will take place. 'He was directly engaged, as he always is, and that was very important. He — members wanted to hear certain assurances from him about what's ahead, what the future will entail, and what we're going to do next, and all of that. And he was very, very helpful in that process,' said Johnson. 'I talked to him multiple times today, tonight, this morning. I mean, he was up, engaged as late as 1am. He may still be up for all I know. He doesn't really sleep a lot, so, you know, directly engaged wanting to know, play by play, what was happening and how he could help and all that.' Johnson also laid out his estimate for the timeline going forward for the morning. 'The group will go down, get the votes necessary to pass the rule. We'll proceed to debate, probably two to three hours for that. There's an hour allotted, but Leader Jeffries gets a Magic Minute. I think he goes about an hour. Mine will be much shorter than that, and we'll proceed a final vote, and we'll be passing this bill, I expect, maybe around 8, 8:30 this morning, maybe sooner, maybe sooner,' he told reporters. 'We'll be gathering on the floor shortly. I'm going to collect — somebody's driving in, they're about to arrive and we'll be moving forward here shortly,' he added. Update: Date: 16 min ago Title: House GOP holdouts fall in line and agree to bring Trump agenda to floor Content: A group of House Republican holdouts fell in line behind President Donald Trump and agreed to allow his agenda to come to the floor — reversing course after days of threatening to block the bill from a final vote. That includes some House hardliners who have complained that the package would add $3.3 trillion to the deficit over the next decade, as well as moderate-leaning members who have concerns about Medicaid cuts. The tally was 219 to 213 with only one GOP no vote: Rep. Brian Fitzpatrick. The House cleared a key procedural hurdle and voted to advance the bill in the early hours of Thursday morning – after House GOP leaders held open the vote on the rule to govern debate for a lengthy period of time as they worked to flip 'no' votes and win over key holdouts. GOP leaders believe they will now have the votes to actually pass Trump's giant tax and spending cuts package when it does come to a full floor vote, but it is not yet certain. Final passage is expected later Thursday morning, after debate, though timing remains fluid. Update: Date: 1 min ago Title: GOP Rep. Ralph Norman flips, says he will back bill after assurances from Trump Content: Rep. Ralph Norman, a conservative who has previously said he was opposed to the Senate-passed version of President Donald Trump's sweeping domestic policy bill, said late last night he will back the bill in the procedural vote and final passage, after receiving assurances from Trump that his concerns will be addressed. 'It's the right thing to do at the right time,' Norman told reporters. Norman said that the president had given conservative holdouts assurances that the green energy tax credits, as well as other conservative priorities, would be 'dealt with' — though Norman refused to say if that would happen by executive order or by future legislative action — during their meeting at the White House yesterday. Some Republicans have been vocal in their opposition to the Senate's slower timeline to phase out some energy tax credits, and Norman said it was important for them to get assurances on that from the White House. 'We got clarification on what's going to be enforced. We got clarification on how the IRAs were going to be dealt with. We got clarification on the tax cuts — and still we'll be meeting tomorrow on the specifics of it. But no, I feel comfortable with this,' Norman said. Pressed on how they can trust leadership will continue to take them seriously, if they still fold, Norman said, 'We get the best we can get, and we go as far as we can go to get for the American people, what we need. That's not bluffing. The reason we have credibility, they know we'll vote no.' He added, 'Now look, this is a game of — and it is a game — of getting the most you can for your consistency. And we're doing that, I'll do that. As long as I'm up here, I'll do that.'
